U.S. flag

An official website of the United States government

NM_020975.6(RET):c.1424G>A (p.Arg475Gln) AND Multiple endocrine neoplasia, type 2

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Nov 4, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000470554.13

Allele description [Variation Report for NM_020975.6(RET):c.1424G>A (p.Arg475Gln)]

NM_020975.6(RET):c.1424G>A (p.Arg475Gln)

Gene:
RET:ret proto-oncogene [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q11.21
Genomic location:
Preferred name:
NM_020975.6(RET):c.1424G>A (p.Arg475Gln)
HGVS:
  • NC_000010.11:g.43111367G>A
  • NG_007489.1:g.39299G>A
  • NM_000323.2:c.1424G>A
  • NM_001355216.2:c.662G>A
  • NM_001406743.1:c.1424G>A
  • NM_001406744.1:c.1424G>A
  • NM_001406759.1:c.1424G>A
  • NM_001406760.1:c.1424G>A
  • NM_001406761.1:c.1295G>A
  • NM_001406762.1:c.1295G>A
  • NM_001406763.1:c.1424G>A
  • NM_001406764.1:c.1295G>A
  • NM_001406765.1:c.1424G>A
  • NM_001406766.1:c.1136G>A
  • NM_001406767.1:c.1136G>A
  • NM_001406768.1:c.1295G>A
  • NM_001406769.1:c.1028G>A
  • NM_001406770.1:c.1136G>A
  • NM_001406771.1:c.986G>A
  • NM_001406772.1:c.1028G>A
  • NM_001406773.1:c.986G>A
  • NM_001406774.1:c.899G>A
  • NM_001406775.1:c.698G>A
  • NM_001406776.1:c.698G>A
  • NM_001406777.1:c.698G>A
  • NM_001406778.1:c.698G>A
  • NM_001406784.1:c.434G>A
  • NM_020629.2:c.1424G>A
  • NM_020630.7:c.1424G>A
  • NM_020975.6:c.1424G>AMANE SELECT
  • NP_000314.1:p.Arg475Gln
  • NP_001342145.1:p.Arg221Gln
  • NP_001342145.1:p.Arg221Gln
  • NP_001393672.1:p.Arg475Gln
  • NP_001393673.1:p.Arg475Gln
  • NP_001393688.1:p.Arg475Gln
  • NP_001393689.1:p.Arg475Gln
  • NP_001393690.1:p.Arg432Gln
  • NP_001393691.1:p.Arg432Gln
  • NP_001393692.1:p.Arg475Gln
  • NP_001393693.1:p.Arg432Gln
  • NP_001393694.1:p.Arg475Gln
  • NP_001393695.1:p.Arg379Gln
  • NP_001393696.1:p.Arg379Gln
  • NP_001393697.1:p.Arg432Gln
  • NP_001393698.1:p.Arg343Gln
  • NP_001393699.1:p.Arg379Gln
  • NP_001393700.1:p.Arg329Gln
  • NP_001393701.1:p.Arg343Gln
  • NP_001393702.1:p.Arg329Gln
  • NP_001393703.1:p.Arg300Gln
  • NP_001393704.1:p.Arg233Gln
  • NP_001393705.1:p.Arg233Gln
  • NP_001393706.1:p.Arg233Gln
  • NP_001393707.1:p.Arg233Gln
  • NP_001393713.1:p.Arg145Gln
  • NP_065680.1:p.Arg475Gln
  • NP_065681.1:p.Arg475Gln
  • NP_065681.1:p.Arg475Gln
  • NP_065681.1:p.Arg475Gln
  • NP_066124.1:p.Arg475Gln
  • NP_066124.1:p.Arg475Gln
  • LRG_518t1:c.1424G>A
  • LRG_518t2:c.1424G>A
  • LRG_518:g.39299G>A
  • LRG_518p1:p.Arg475Gln
  • LRG_518p2:p.Arg475Gln
  • NC_000010.10:g.43606815G>A
  • NM_001355216.1:c.662G>A
  • NM_020630.4:c.1424G>A
  • NM_020630.6:c.1424G>A
  • NM_020975.4:c.1424G>A
  • P07949:p.Arg475Gln
Protein change:
R145Q
Links:
UniProtKB: P07949#VAR_006305; dbSNP: rs138624658
NCBI 1000 Genomes Browser:
rs138624658
Molecular consequence:
  • NM_000323.2:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001355216.2:c.662G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406743.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406744.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406759.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406760.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406761.1:c.1295G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406762.1:c.1295G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406763.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406764.1:c.1295G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406765.1:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406766.1:c.1136G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406767.1:c.1136G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406768.1:c.1295G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406769.1:c.1028G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406770.1:c.1136G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406771.1:c.986G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406772.1:c.1028G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406773.1:c.986G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406774.1:c.899G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406775.1:c.698G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406776.1:c.698G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406777.1:c.698G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406778.1:c.698G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406784.1:c.434G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020629.2:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020630.7:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020975.6:c.1424G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
3

Condition(s)

Name:
Multiple endocrine neoplasia, type 2 (MEN2)
Identifiers:
MONDO: MONDO:0019003; MedGen: C4048306

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000543838Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 4, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004821574All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Sep 5, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown3not providednot provided108544not providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations.

Kjaer S, Hanrahan S, Totty N, McDonald NQ.

Nat Struct Mol Biol. 2010 Jun;17(6):726-31. doi: 10.1038/nsmb.1808. Epub 2010 May 16.

PubMed [citation]
PMID:
20473317
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000543838.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 475 of the RET protein (p.Arg475Gln). This variant is present in population databases (rs138624658, gnomAD 0.007%). This missense change has been observed in individual(s) with Hirschsprung disease (PMID: 20473317). ClinVar contains an entry for this variant (Variation ID: 135188). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004821574.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (3)

Description

This missense variant replaces arginine with glutamine at codon 475 of the RET protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been observed in an individual with sporadic Hirschsprung disease (PMID: 20473317) and has also been identified in a healthy subject (PMID: 24728327) This variant has been identified in 3/251358 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided3not providednot providednot provided

Last Updated: May 16, 2025